UK 04:50 Saturday, 19 September 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Successful investing in the biotechnology sector requires a disciplined approach and painstaking due diligence. It is as much about avoiding the losers as it is about picking winners, and experience undoubtedly helps. Having met thousands of companies over the years, our instincts are finely tuned – there are certain characteristics we regularly see that will immediately rule an opportunity out as a potential investment.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
